Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of a Novel Blood Test to Identify Breast Cancer (IDBC)

NCT04495244 is registered in ClinicalTrials.gov with Syantra Inc. as lead sponsor.

NCT NCT04495244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04495244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of a Novel Blood Test to Identify Breast Cancer (IDBC)
Lead sponsor
Syantra Inc.
Phase
Observational
Overall status
Recruiting
Start date
January 24, 2019
Completion date
December 31, 2032
Enrollment
10,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female